Tenofovir dipivoxil/Levocarnitine

替诺福韦卡尼汀

Report date: 2025/07/31 10:53:57

Base Information

Drug NameTenofovir dipivoxil/Levocarnitine
Drug Alias Name替诺福韦双特戊酯/左卡尼汀
ClassificationSmall molecules
Mechanisms of ActionCarnitine acetylase stimulantsReverse transcriptase inhibitors
TargetsCarnitine acetylaseReverse transcriptase
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusPending (IND)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A